ArticleCrohn's & colitis 3602026

Mirikizumab is equally effective in ustekinumab-exposed and ustekinumab-naïve patients with UC: a multicenter real-world cohort.

Mohmmed Tauseef Sharip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.